EZH2 and hepatocellular carcinoma: Upregulated enhancer of zeste homolog 2 (EZH2) in HCC, a well-studied chromatin modifier which mediates gene silencing in HCC, represses miR-622 by enhancing H3K27 trimethylation, and is correlated with unfavorable HCC prognosis (32).